+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Axial Spondyloarthritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767631
  • Report
  • April 2019
  • Region: Global
  • 102 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • Eli Lilly and Co
  • Johnson & Johnson
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Axial Spondyloarthritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Axial Spondyloarthritis. It presents in-depth analysis of Axial Spondyloarthritis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Axial Spondyloarthritis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Axial Spondyloarthritis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Axial Spondyloarthritis

The research work is prepared through extensive and continuous research on Axial Spondyloarthritis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Axial Spondyloarthritis patients are identified
  • The report includes panorama of Axial Spondyloarthritis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Axial Spondyloarthritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • Eli Lilly and Co
  • Johnson & Johnson
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Axial Spondyloarthritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Axial Spondyloarthritis Clinical Trials by Region
2.2.2 Average Enrollment of Axial Spondyloarthritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Axial Spondyloarthritis Treatment, 2019

3. Region wise Axial Spondyloarthritis Clinical Trials
3.1 Asia Pacific Axial Spondyloarthritis Clinical Trials by Country
3.2 Europe Axial Spondyloarthritis Clinical Trials by Country
3.3 North America Axial Spondyloarthritis Clinical Trials by Country
3.4 Middle East and Africa Axial Spondyloarthritis Clinical Trials by Country
3.5 South and Central America Axial Spondyloarthritis Clinical Trials by Country

4. Axial Spondyloarthritis Clinical Trial Trends
4.1 Start Year wise Axial Spondyloarthritis Clinical Trials
4.2 Phase wise Axial Spondyloarthritis Clinical Trials
4.3 Trial Status wise Axial Spondyloarthritis Clinical Trials
4.4 Trial Type wise Axial Spondyloarthritis Clinical Trials

5. Axial Spondyloarthritis Average Enrollment Trends
5.1 Average Enrollment in Axial Spondyloarthritis Trials by Year
5.2 Average Enrollment in Axial Spondyloarthritis Trials by Phase
5.3 Average Enrollment in Axial Spondyloarthritis Trials by Status
5.4 Average Enrollment in Axial Spondyloarthritis Trials by Type of Trial

6. Companies Participating in Axial Spondyloarthritis Clinical Trials
6.1 Axial Spondyloarthritis Trials by Sponsor Type
6.2 Axial Spondyloarthritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Axial Spondyloarthritis Trials- Phase 1
7.2 Axial Spondyloarthritis Trials- Phase 2
7.3 Axial Spondyloarthritis Trials- Phase 3
7.4 Axial Spondyloarthritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Axial Spondyloarthritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Figure 9: Axial Spondyloarthritis Clinical Trials by Phase
Figure 10: Axial Spondyloarthritis Clinical Trials by Trial Status
Figure 11: Axial Spondyloarthritis Clinical Trials by Type
Figure 12: Axial Spondyloarthritis Clinical Trials by Sponsor Type
Figure 13: Axial Spondyloarthritis Clinical Trials by Leading Sponsors
Figure 14: Axial Spondyloarthritis Average Enrollment by Phase
Figure 15: Axial Spondyloarthritis Average Enrollment by Trial Status
Figure 16: Axial Spondyloarthritis Average Enrollment by Type
Figure 17: Axial Spondyloarthritis- Average Enrolment by Type of Sponsors
Figure 18: Axial Spondyloarthritis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Axial Spondyloarthritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Table 7: North America - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Axial Spondyloarthritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Axial Spondyloarthritis Average Enrollment by Phase
Table 15: Axial Spondyloarthritis Average Enrollment by Trial Status
Table 16: Axial Spondyloarthritis Average Enrollment by Type
Table 17: Axial Spondyloarthritis- Average Enrolment by Type of Sponsors
Table 18: Axial Spondyloarthritis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • UCB SA
  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • Eli Lilly and Co
  • Johnson & Johnson
  • Merck & Co Inc
  • Novartis AG
  • Pamplona Capital Management LLP
  • Pfizer Inc
Note: Product cover images may vary from those shown
Adroll
adroll